RESEARCHER PROFILE

Abdulilah Ece

← Back to Biruni University

A

Biruni University

Synthesis and biological activitySynthesis and Characterization of Heterocyclic CompoundsComputational Drug Discovery MethodsCholinesterase and Neurodegenerative DiseasesEnzyme function and inhibition

Abdulilah Ece works in Synthesis and biological activity, Synthesis and Characterization of Heterocyclic Compounds, Computational Drug Discovery Methods, Cholinesterase and Neurodegenerative Diseases, Enzyme function and inhibition. Recorded institutional associations include Biruni University.

90Publications
1,858Citations
26H-index

Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.

Selected research works

Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.

  1. Synthesis, molecular modeling, and biological evaluation of 4‐[5‐aryl‐3‐(thiophen‐2‐yl)‐4,5‐dihydro‐1H‐pyrazol‐1‐yl] benzenesulfonamides toward acetylcholinesterase, carbonic anhydrase I and II enzymes

    2017 · 146 citations
  2. Design, synthesis, characterization, in vitro and in silico evaluation of novel imidazo[2,1-b][1,3,4]thiadiazoles as highly potent acetylcholinesterase and non-classical carbonic anhydrase inhibitors

    2021 · 107 citations
  3. New bis- and tetrakis-1,2,3-triazole derivatives: Synthesis, DNA cleavage, molecular docking, antimicrobial, antioxidant activity and acid dissociation constants

    2021 · 81 citations
  4. Computer-aided drug design

    2023 · 77 citations
  5. Novel spiroindoline derivatives targeting aldose reductase against diabetic complications: Bioactivity, cytotoxicity, and molecular modeling studies

    2024 · 76 citations
  6. Novel beta-lactam substituted benzenesulfonamides: in vitro enzyme inhibition, cytotoxic activity and in silico interactions

    2023 · 74 citations
  7. Bioactivity, cytotoxicity, and molecular modeling studies of novel sulfonamides as dual inhibitors of carbonic anhydrases and acetylcholinesterase

    2024 · 73 citations
  8. N-substituted phthalimide–carboxylic acid hybrids as dual-targeted aldose reductase inhibitors: Synthesis, mechanistic insights, and cancer-relevant profiling

    2025 · 71 citations
  9. Towards more effective acetylcholinesterase inhibitors: a comprehensive modelling study based on human acetylcholinesterase protein–drug complex

    2019 · 64 citations
  10. Chalcone-inspired indole, carbazole, and phenothiazine hybrids as potent aldose reductase inhibitors with selective anticancer potential: Rational design, synthesis, and multi-level characterization

    2025 · 61 citations
  11. Design, synthesis and molecular modelling studies of some pyrazole derivatives as carbonic anhydrase inhibitors

    2019 · 55 citations
  12. Quinazolinone-based benzenesulfonamides with low toxicity and high affinity as monoamine oxidase-A inhibitors: Synthesis, biological evaluation and induced-fit docking studies

    2022 · 54 citations
  13. Design, Synthesis, SAR and Molecular Modeling Studies of Novel Imidazo[2,1‐b][1,3,4]Thiadiazole Derivatives as Highly Potent Antimicrobial Agents

    2017 · 50 citations
  14. Comprehensive study on potent and selective carbonic anhydrase inhibitors: Synthesis, bioactivities and molecular modelling studies of 4-(3-(2-arylidenehydrazine-1-carbonyl)-5-(thiophen-2-yl)-1H-pyrazole-1-yl) benzenesulfonamides

    2021 · 49 citations
  15. Synthesis, biological evaluation and in silico modelling studies of 1,3,5-trisubstituted pyrazoles carrying benzenesulfonamide as potential anticancer agents and selective cancer-associated hCA IX isoenzyme inhibitors

    2019 · 47 citations
  16. Phthalimide–benzoic acid hybrids as potent aldose reductase inhibitors: Synthesis, enzymatic kinetics, and in silico characterization

    2025 · 47 citations
  17. Novel imidazo[2,1‐b]thiazole‐based anticancer agents as potential focal adhesion kinase inhibitors: Synthesis, in silico and in vitro evaluation

    2021 · 42 citations
  18. Synthesis, characterization, preliminary SAR and molecular docking study of some novel substituted imidazo[2,1-b][1,3,4]thiadiazole derivatives as antifungal agents

    2017 · 41 citations
  19. Redox Pathways of Aliskiren Based on Experimental and Computational Approach and Its Voltammetric Determination

    2013 · 39 citations
  20. The discovery of potential cyclin A/CDK2 inhibitors: a combination of 3D QSAR pharmacophore modeling, virtual screening, and molecular docking studies

    2013 · 37 citations
  21. Epichlorohydrin and tripolyphosphate-crosslinked chitosan–kaolin composite for Auramine O dye removal from aqueous solutions: Experimental study and DFT calculations

    2022 · 37 citations
  22. Novel coumarin-chalcone derivatives: Synthesis, characterization, antioxidant, cyclic voltammetry, molecular modelling and biological evaluation studies as acetylcholinesterase, α-glycosidase, and carbonic anhydrase inhibitors

    2023 · 34 citations
  23. Structural characterization and biological evaluation of uracil-appended benzylic amines as acetylcholinesterase and carbonic anhydrase I and II inhibitors

    2023 · 32 citations
  24. Synthesis, Biological Evaluation, Molecular Docking, and Acid Dissociation Constant of New Bis‐1,2,3‐triazole Compounds

    2021 · 30 citations
  25. Synthesis, anti-inflammatory activity, inverse molecular docking, and acid dissociation constants of new naphthoquinone-thiazole hybrids

    2023 · 30 citations

← Return to the university profile